Catheter Precision (VTAK) to Release Quarterly Earnings on Friday

Catheter Precision (NYSEAMERICAN:VTAK) will likely be releasing its earnings data before the market opens on Friday, April 4th. Analysts expect Catheter Precision to post earnings of ($0.20) per share and revenue of $0.28 million for the quarter.

Catheter Precision Price Performance

VTAK opened at $0.38 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 0.65 and a current ratio of 0.66. The stock has a fifty day moving average price of $0.40. Catheter Precision has a one year low of $0.30 and a one year high of $8.40.

Catheter Precision Company Profile

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.